Sharechat Logo

Green Cross Health Limited - Annual Shareholders' Meeting

Thursday 29th June 2023

Text too small?

Notice is hereby given that the 2023 Annual Meeting of Shareholders of Green Cross Health Limited (“the Company”) will be held at the Ellerslie Event Centre 80 Ascot Avenue Greenlane Auckland on Monday, 31st of July 2023 at 2.30 pm.

 

BUSINESS:

 

A. Chair’s Address

B. Group Chief Executive Officer’s Address

C. Audited Financial Statements

D. Resolutions

 

To consider and, if thought fit, to pass the following ordinary resolutions:

 

1. That Andrew Bagnall be re-elected as a Director of the Company

2. That Carolyn Steele be re-elected as a Director of the Company

3. To authorise the Directors to fix the remuneration of the Auditor for the ensuing year.

 

E. To consider any other matters that may be properly brought before the Annual Meeting.

 

Proxies and voting

 

Any shareholder who is entitled to attend and vote at the meeting may instead appoint a proxy to attend and vote on their behalf. The Chair of the Company is willing to act as proxy for any shareholder who may wish to appoint him for that purpose. The Chair intends to vote any undirected proxies in favour of the resolutions.

 

If you wish to appoint a proxy please complete the enclosed proxy form and mail to:

 

Computershare Investor Services limited

Private Bag 92119

Auckland 1142

 

Alternatively, you can complete a proxy form online at www.investorvote.co.nz. You will need the Control Number (found on the Proxy Notice), your CSN/security holder number and postcode or country of residence to vote online.

 

In either case, for your vote to be effective, your proxy must be received no later than 48 hours before the time of holding the meeting.

 

Note

Biographical information relating to the Directors standing for re-election at the meeting can be found below.

 

Afternoon tea will be served at the conclusion of the meeting.

 

For and on behalf of the Board

 

Ben Doshi

Group Chief Financial Officer/Company Secretary

Dated: 27 June 2023

 

Biographical information relating to the Directors standing for re-election:

 

Andrew Bagnall

Non-Executive Director

 

Andrew Bagnall holds a Commerce Degree from Otago University and a MBA from Michigan State University. Andrew was a significant investor in Life Pharmacy Limited and following the merger with Pharmacybrands Limited (later renamed Green Cross Health Limited) has continued to hold a shareholding in the merged entity.

 

In Andrew’s earlier career, he was a leading figure in the New Zealand travel industry establishing and managing Gullivers Travel Group which became the major distributor of wholesale and retail travel services in New Zealand. Gullivers Travel Group was eventually listed on the New Zealand and Australian stock exchanges (ASX) and was subsequently sold to ASX listed S8. Andrew was also involved in co-developing one of New Zealand’s first commercial retirement villages. Andrew now runs his own private investment company, Segoura, which manages investments in various businesses. Andrew is also a Director of PowerShield Limited, Steelmasters Auckland Limited and he maintains a keen interest in sports car racing.

 

Andrew was appointed as a Non-Executive Director of the Company in August 2009.

 

Carolyn Steele

Independent Director

 

Carolyn Steele is a director of WEL Networks Limited, Oriens Capital GP 2 Limited, Property for Industry and Vulcan Steel Limited and chair of The Halberg Foundation. Until 2016, Carolyn was a Portfolio Manager at Guardians of New Zealand Superannuation, the Crown entity managing the New Zealand Superannuation Fund. Prior to joining the Guardians in 2010, Carolyn spent ten years in investment banking at Forsyth Barr and Credit Suisse/First NZ Capital.

 

Carolyn was appointed as an Independent Director of the Company in June 2017.



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

WCO - James Redmayne to resign from executive role
Fletcher Building Market Update
Devon Funds Morning Note - 13 May 2024
GTK - Half-Year Results Investor Briefing Details
GNE - Huntly Firming Options
Chatham Closes Private Placement
May 13th Morning Report
Rakon FY2024 Results Announcement Date
WHS - The Warehouse Group FY24 Third Quarter Sales Update
May 10th Morning Report